サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1458674

感染予防の世界市場レポート 2024年

Infection Prevention Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
感染予防の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

感染予防の市場規模は、今後数年間で安定した成長が見込まれます。2028年には年間平均成長率（CAGR）3.7％で502億1,000万米ドルに成長します。今後の成長予測は、感染症の出現、技術の進歩、世界の人口増加、外来医療サービスの増加など、いくつかの要因によってもたらされます。この期間に予測される主な動向には、遠隔医療およびデジタルヘルスソリューションの拡大、個別化感染予防戦略の開発、人工知能（AI）への依存の高まり、迅速診断ツールの使用、行動介入への注目の高まりなどがあります。

院内感染（HAI）の増加が感染予防市場の成長を牽引すると予想されます。HAIは、患者が病院やその他のヘルスケア施設でヘルスケア治療を受けている間に感染する感染症です。感染予防戦略は、HAIのリスクを低減し、患者の安全性を向上させることを目的としています。例えば、オーストラリア保健福祉研究所によると、2021-22年に病院から報告された黄色ブドウ球菌血流感染症（SABSI）は1,546件で、患者1万日当たりの感染率は0.73件でした。HAIの増加は、感染予防市場の成長を促進する重要な要因です。

感染予防市場の主なプレーヤーは、感染予防ist人員配置計算機などの新製品を開発し、サービス提供を強化することで革新を図っています。これらの計算機は、病床数、患者の急性期、施設のタイプなどの要因に基づいて、ヘルスケア施設に必要な感染予防istの数を推定するのに役立ちます。例えば、Association for Professionals in Infection Control and Epidemiology（APIC）は、2023年12月に感染予防ist人員計算ツールを開始しました。このツールは、病院や診療所が必要な感染予防ist（IP）の適切な数を決定するのに役立ち、最適な人員配置によって患者の安全性を向上させます。ヘルスケア施設からのデータを使用して計算機を継続的に改良することで、正確な人員配置の推奨が可能になります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19感染症による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の感染予防市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 滅菌装置
  • 消毒剤
  • 消耗品
  • 世界の感染予防市場、感染症タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 微生物感染症
  • ヘルスケア関連の感染症
  • 世界の感染予防市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院と診療所
  • 製薬会社
  • 臨床検査室
  • 医療機器企業
  • ライフサイエンス産業
  • 学術研究センター

第7章 地域および国の分析

  • 世界の感染予防市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の感染予防市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 感染予防市場の競合情勢
  • 感染予防市場企業プロファイル
    • Cardinal Health Inc.
    • 3M Company
    • Stryker Corporation
    • Reckitt Benckiser Group plc
    • Ecolab Inc.

第31章 その他の主要および革新的な企業

  • B. Braun Melsungen AG
  • The Clorox Company
  • Olympus Corporation
  • Fortive Corporation
  • Steris PLC
  • Genitge AB
  • Sotera Health Inc.
  • Belimed AG
  • Coltene Group
  • Steelco SpA
  • Skytron LLC
  • Melag Medizintechnik GmbH &Co. KG
  • Metrex Research
  • Pal International
  • Cisa Production Srl Unipersonale

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16655

Infection prevention encompasses a range of measures and practices aimed at reducing the risk and spread of infectious diseases. These practices include hygiene measures such as regular hand washing, vaccination, and the use of protective equipment. They play a critical role in healthcare settings, public spaces, and personal care to safeguard both individual and public health.

The key product categories within infection prevention include sterilization equipment, disinfectors, and consumables. Sterilization equipment is used to eliminate all forms of microbial life, including bacteria, viruses, and spores, from surfaces, fluids, medications, or biological culture media. Various types of infections, including microbial and healthcare-associated infections, are targeted by these products. They are utilized by a range of end-users such as hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device companies, the life science industry, and academic and research centers.

The infection prevention market research report is one of a series of new reports from The Business Research Company that provides infection prevention market statistics, including infection prevention industry global market size, regional shares, competitors with an infection prevention market share, detailed infection prevention market segments, market trends, and opportunities, and any further data you may need to thrive in the infection prevention industry. This infection prevention market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection prevention market size has grown steadily in recent years. It will grow from $41.64 billion in 2023 to $43.40 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, advancements in technology, globalization and international travel, and rising healthcare expenditure.

The infection prevention market size is expected to see steady growth in the next few years. It will grow to $50.21 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The forecasted growth in the upcoming period is driven by several factors, including the emergence of infectious diseases, technological advancements, global population growth, and an increase in ambulatory care services. Key trends anticipated during this period include the expansion of telemedicine and digital health solutions, the development of personalized infection prevention strategies, a greater reliance on artificial intelligence (AI), the use of rapid diagnostic tools, and a heightened focus on behavioral interventions.

The rise in hospital-acquired infections (HAIs) is expected to drive the growth of the infection prevention market. HAIs are infections that patients contract while receiving healthcare treatment in a hospital or other healthcare facility. Infection prevention strategies aim to reduce the risk of HAIs and improve patient safety. For example, according to the Australian Institute of Health and Welfare, hospitals reported 1,546 cases of Staphylococcus aureus bloodstream infections (SABSIs) in 2021-22, with a rate of 0.73 cases per 10,000 patient days. The increase in HAIs is a key factor propelling the growth of the infection prevention market.

Key players in the infection prevention market are innovating by developing new products such as infection preventionist staffing calculators to enhance their service offerings. These calculators help estimate the required number of infection preventionists in a healthcare facility based on factors such as bed count, patient acuity, and facility type. For example, the Association for Professionals in Infection Control and Epidemiology (APIC) launched an infection preventionist staffing calculator in December 2023. This tool aids hospitals and clinics in determining the appropriate number of infection preventionists (IPs) needed, thereby improving patient safety through optimal staffing levels. Continuous refinement of the calculator using data from healthcare facilities ensures accurate staffing recommendations.

In July 2021, Steris plc, an Ireland-based medical device company, completed the acquisition of Cantel Medical Corporation for $3.6 billion. This strategic move enhances Steris's infection prevention capabilities, expands its global footprint, and strengthens its customer base, particularly in the fields of endoscopy and dentistry. Cantel Medical Corporation, based in the US, is a renowned manufacturer of infection prevention and control products.

Major companies operating in the infection prevention market report are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Genitge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale, Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC, Matachana SA

North America was the largest region in the infection prevention market in 2023. The regions covered in the infection prevention market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infection prevention market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infection prevention market consists of revenues earned by entities by providing services such as disinfection, sterilization, and isolation precautions. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection prevention market consists of sales of hand hygiene products, personal protective equipment (PPE), antimicrobial wipes and sprays, sharps disposal containers, and biohazard bags. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infection Prevention Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infection prevention market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infection prevention? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infection prevention market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Sterilization Equipment; Disinfectors; Consumables
  • 2) By Infection Type: Microbial Infections; Healthcare Associated Infections
  • 3) By End User: Hospitals And Clinics; Pharmaceutical Companies; Clinical Laboratories; Medical Device Companies; Life Science Industry; Academic And Research Center
  • Companies Mentioned: Cardinal Health Inc.; 3M Company; Stryker Corporation; Reckitt Benckiser Group plc; Ecolab Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infection Prevention Market Characteristics

3. Infection Prevention Market Trends And Strategies

4. Infection Prevention Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Infection Prevention Market Size and Growth

  • 5.1. Global Infection Prevention Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Infection Prevention Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Infection Prevention Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Infection Prevention Market Segmentation

  • 6.1. Global Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sterilization Equipment
  • Disinfectors
  • Consumables
  • 6.2. Global Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Microbial Infections
  • Healthcare Associated Infections
  • 6.3. Global Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Pharmaceutical Companies
  • Clinical Laboratories
  • Medical Device Companies
  • Life Science Industry
  • Academic And Research Center

7. Infection Prevention Market Regional And Country Analysis

  • 7.1. Global Infection Prevention Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Infection Prevention Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Infection Prevention Market

  • 8.1. Asia-Pacific Infection Prevention Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Infection Prevention Market

  • 9.1. China Infection Prevention Market Overview
  • 9.2. China Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Infection Prevention Market

  • 10.1. India Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Infection Prevention Market

  • 11.1. Japan Infection Prevention Market Overview
  • 11.2. Japan Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Infection Prevention Market

  • 12.1. Australia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Infection Prevention Market

  • 13.1. Indonesia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Infection Prevention Market

  • 14.1. South Korea Infection Prevention Market Overview
  • 14.2. South Korea Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Infection Prevention Market

  • 15.1. Western Europe Infection Prevention Market Overview
  • 15.2. Western Europe Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Infection Prevention Market

  • 16.1. UK Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Infection Prevention Market

  • 17.1. Germany Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Infection Prevention Market

  • 18.1. France Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Infection Prevention Market

  • 19.1. Italy Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Infection Prevention Market

  • 20.1. Spain Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Infection Prevention Market

  • 21.1. Eastern Europe Infection Prevention Market Overview
  • 21.2. Eastern Europe Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Infection Prevention Market

  • 22.1. Russia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Infection Prevention Market

  • 23.1. North America Infection Prevention Market Overview
  • 23.2. North America Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Infection Prevention Market

  • 24.1. USA Infection Prevention Market Overview
  • 24.2. USA Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Infection Prevention Market

  • 25.1. Canada Infection Prevention Market Overview
  • 25.2. Canada Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Infection Prevention Market

  • 26.1. South America Infection Prevention Market Overview
  • 26.2. South America Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Infection Prevention Market

  • 27.1. Brazil Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Infection Prevention Market

  • 28.1. Middle East Infection Prevention Market Overview
  • 28.2. Middle East Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Infection Prevention Market

  • 29.1. Africa Infection Prevention Market Overview
  • 29.2. Africa Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Infection Prevention Market Competitive Landscape And Company Profiles

  • 30.1. Infection Prevention Market Competitive Landscape
  • 30.2. Infection Prevention Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. 3M Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Stryker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Reckitt Benckiser Group plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ecolab Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Infection Prevention Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. The Clorox Company
  • 31.3. Olympus Corporation
  • 31.4. Fortive Corporation
  • 31.5. Steris PLC
  • 31.6. Genitge AB
  • 31.7. Sotera Health Inc.
  • 31.8. Belimed AG
  • 31.9. Coltene Group
  • 31.10. Steelco S.p.A.
  • 31.11. Skytron LLC
  • 31.12. Melag Medizintechnik GmbH & Co. KG
  • 31.13. Metrex Research
  • 31.14. Pal International
  • 31.15. Cisa Production S.r.l. Unipersonale

32. Global Infection Prevention Market Competitive Benchmarking

33. Global Infection Prevention Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Infection Prevention Market

35. Infection Prevention Market Future Outlook and Potential Analysis

  • 35.1 Infection Prevention Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Infection Prevention Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Infection Prevention Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer